Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta‐analysis

Published:2022-08-02 Issue:9 Volume:24 Page:1677-1696
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Antonopoulos Alexios S.¹,Panagiotopoulos Ioannis¹,Kouroutzoglou Alexandrina¹,Koutsis Georgios²,Toskas Pantelis¹,Lazaros Georgios¹,Toutouzas Konstantinos¹,Tousoulis Dimitris¹,Tsioufis Konstantinos¹,Vlachopoulos Charalambos¹

Affiliation:

1. 1st Cardiology Department National and Kapodistrian University of Athens, Hippokration University Hospital Athens Greece

2. Neurogenetics Unit, 1st Department of Neurology National and Kapodistrian University of Athens, Eginition University Hospital Athens Greece

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2589

Reference166 articles.

1. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

2. Natural history and impact of treatment with tafamidis on major cardiovascular outcome‐free survival time in a cohort of patients with transthyretin amyloidosis

3. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

4. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

5. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy;Scientific Reports;2024-09-03

2. Editorial comment regarding article: Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis;Clinical Research in Cardiology;2024-09-02

3. Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis;Clinical Research in Cardiology;2024-08-06

4. Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo, Brazil (REACT-SP);Orphanet Journal of Rare Diseases;2024-07-20

5. Phenotype and prognostic factors in geriatric and non‐geriatric patients with transthyretin cardiomyopathy;ESC Heart Failure;2024-07-17